Last updated: 19 November 2026
Can you take CBD with immunosuppressants? Only if your transplant, IBD or rheumatology team agrees first, then your GP or pharmacist. The tacrolimus and ciclosporin product information warns that CBD can raise their blood levels, and the BNF also lists sirolimus and everolimus. Nothing has been studied for azathioprine or mycophenolate.
Never stop, skip or change an immunosuppressant to try CBD. This is general information, not medical advice.
Can you take CBD with immunosuppressants?
Nobody can promise it is safe. Immunosuppressants are used after an organ transplant and for conditions such as Crohn’s disease, ulcerative colitis and rheumatoid arthritis. Several work only inside a narrow range, which is why your team checks your blood so often. Almost everything known about CBD with them comes from prescription CBD (Epidyolex) and small high-dose studies. CBD food supplements have not been tested with any immunosuppressant.
The Food Standards Agency (FSA) advises, as a precaution, that people taking any medication should not use CBD unless under medical direction. It also says CBD labels should tell anyone taking medicines or who is immunosuppressed to consult a healthcare professional before using the product. So ask your transplant unit, IBD nurse or rheumatology team first, then your GP or community pharmacist.
Related guides: CBD and methotrexate, CBD and prednisolone, CBD and blood tests and can CBD interact with medication?
What the BNF and product information say
The BNF is the reference UK doctors and pharmacists use. Its cannabidiol list has 181 entries. Checked at source on 19 November 2026:
| Medicine | What the sources say | What it means for you |
|---|---|---|
| Tacrolimus (Prograf, Advagraf, Adoport) | Reports of raised tacrolimus levels with CBD; BNF rates it moderate | Your team may need to check levels and adjust the dose |
| Ciclosporin (Neoral) | CBD predicted to raise levels; BNF rates it severe | Do not start CBD without your specialist |
| Sirolimus and everolimus | CBD raised everolimus about 2.5 times in volunteers; sirolimus may rise too | Level checks and dose changes may be needed |
| Azathioprine and mycophenolate | Not on the BNF cannabidiol list | Not studied, which is not the same as safe |
The BNF’s cannabidiol entries come from Epidyolex, a licensed CBD medicine given at high doses, not from food supplements.
Tacrolimus and CBD
Tacrolimus has the clearest warning. The Prograf product information says there have been reports of increased tacrolimus blood levels when it is used with cannabidiol, possibly because CBD blocks a pump in the gut wall (P-glycoprotein) that normally limits how much tacrolimus is absorbed. It says the two should be used together with caution, with close monitoring for side effects, tacrolimus trough levels checked and the dose adjusted if needed.
The Epidyolex product information agrees: CBD may increase exposure to tacrolimus and sirolimus taken by mouth, so level checks and lower doses should be considered. What studies have found:
- A case report (Leino and colleagues, 2019). A person on tacrolimus in a CBD epilepsy trial had about 3 times higher tacrolimus levels for their dose while taking 2,000 to 2,900mg of prescription CBD a day.
- A healthy volunteer trial (So and colleagues, 2025). In 12 people who took CBD at 5mg per kg twice a day for 14 days, the peak tacrolimus level after a single dose rose 4.2 times and total exposure 3.1 times. The authors said their results suggest transplant patients taking CBD need tacrolimus dose reductions and frequent level checks.
- Kidney transplant patients in Uruguay (Cuñetti and colleagues, 2018). Seven people took 100 to 300mg of CBD a day for 3 weeks, with blood tests every 2 days in the first week. Tacrolimus levels varied, two people had their tacrolimus dose lowered (one had high levels even before CBD), and those on ciclosporin were stable.
All of these doses are far above the FSA’s advised maximum of 10mg a day for healthy adults. Nobody has tested a 10mg supplement with tacrolimus, so a smaller amount cannot be assumed to be safe. The Prograf product information also says herbal preparations should be avoided while taking it, and that levels can change during bouts of diarrhoea.
iUse tacrolimus ointment for eczema? Ask your pharmacist; that hasn’t been studied with CBD either.
Ciclosporin and CBD
The BNF marks CBD with ciclosporin as severe, based on theory rather than a study. The Neoral product information says raised levels of a related medicine (tacrolimus) have been reported with CBD, so the two should be used together with caution, with ciclosporin levels monitored in transplant patients and considered in others.
Ciclosporin is broken down mainly by the liver enzyme CYP3A4 and handled by the P-glycoprotein pump. CBD blocks CYP3A4 in lab studies (Yamaori and colleagues, 2011), though the Epidyolex product information found no effect on CYP3A4 in people. A 2024 case report from Uruguay (Cuñetti and colleagues) described an interaction between CBD, ciclosporin and mycophenolate in a kidney transplant patient, and the authors stressed monitoring drug levels.
The BNF also lists ciclosporin for severe ulcerative colitis, rheumatoid arthritis, psoriasis, eczema and nephrotic syndrome. The same advice applies whatever you take it for. Grapefruit and grapefruit juice can raise ciclosporin levels too, the Neoral product information says.
Sirolimus and everolimus
- Everolimus. In a healthy volunteer study in the Epidyolex product information, CBD raised everolimus levels about 2.5 times. It says to monitor everolimus levels and adjust the dose when starting CBD. The BNF rates this moderate. Everolimus also appears in the epilepsy section of that product information; see CBD and epilepsy medication.
- Sirolimus (Rapamune). The BNF says CBD is predicted to increase exposure to sirolimus and the manufacturer advises monitoring and adjusting the dose.
Azathioprine and mycophenolate
Neither is on the BNF’s cannabidiol list or in the Epidyolex product information. No interaction has been documented, but none has been ruled out.
- Azathioprine. The NHS says it is used for Crohn’s disease, ulcerative colitis, rheumatoid arthritis and after organ transplants. Its product information describes it being processed by enzymes such as TPMT and xanthine oxidase, which is why allopurinol interacts with it. You’ll need regular blood tests to monitor your liver and bone marrow, the NHS says, and it asks you to tell your doctor about any herbal remedies, vitamins or supplements before taking it.
- Mycophenolate (CellCept, Myfortic). The BNF lists it to help prevent rejection after kidney, heart and liver transplants, alongside ciclosporin and a steroid. Apart from the single Uruguay case report above, it hasn’t been studied with CBD.
Liver tests are one more reason to tell your team: the Epidyolex product information says prescription CBD can raise liver enzymes, which could muddy the results your team relies on. More in CBD and blood tests. Taking methotrexate or steroid tablets too? See CBD and methotrexate and CBD and prednisolone.
Blood level checks and why they matter
Tacrolimus, ciclosporin, sirolimus and everolimus doses are set by measuring the amount in your blood just before a dose (the trough level). The BNF says tacrolimus doses are adjusted by whole blood trough levels, and that ciclosporin levels and magnesium should be monitored.
The Prograf product information says medicines that push tacrolimus levels up can cause serious side effects, including kidney and nerve problems, while anything that pushes levels down raises the risk of rejection. It also says stopping such a product can change levels the other way.
If you already take CBD: tell your transplant, IBD or rheumatology team now, and before your next blood test. Don’t stop or start it on your own without telling them, as either can change your levels. Keep taking your immunosuppressant exactly as prescribed.
NHS Blood and Transplant says to take transplant medicines exactly as your team prescribed them, and to tell the team about missed doses.
When to get help and support
Call your transplant unit or specialist team’s advice line if you feel unwell, if you’ve been told your levels are out of range, or if you’ve missed or doubled a dose.
Call NHS 111 if you can’t reach them, or if you’ve taken more of your medicine than prescribed. Call 999 in an emergency.
Support lines (checked 19 November 2026):
- Kidney Care UK Support Line: 0808 801 00 00, free, Monday to Friday 9am to 5pm.
- Liver UK (formerly the British Liver Trust) nurse-led helpline: 0800 652 7330, Monday to Friday 9am to 4pm, not bank holidays.
- Crohn’s and Colitis UK helpline: 0300 222 5700, Monday to Friday 10am to 3pm.
- Arthritis UK (formerly Versus Arthritis) helpline: 0800 5200 520, free, Monday to Friday 9am to 6pm.
Questions for your team
iAsk your transplant, IBD or rheumatology team first, then your GP or pharmacist. Take your medicine list and a photo of the CBD label:
- Is CBD reasonable with my immunosuppressant and dose, or should I avoid it?
- If I go ahead, would you want an extra level check, and when?
- Which side effects should make me stop and call you?
Sources 11
- emc. Epidyolex SmPC, revised 8 June 2026; Prograf SmPC, revised 11 March 2026; Neoral SmPC, revised 25 February 2026; azathioprine SmPC, revised 30 October 2026. Checked 19 November 2026.
- BNF (NICE). Cannabidiol interactions, tacrolimus and ciclosporin. Checked 19 November 2026.
- NHS. Azathioprine. Reviewed 19 October 2026; checked 19 November 2026.
- NHS Blood and Transplant. Kidney transplant medicines. Checked 19 November 2026.
- Food Standards Agency (GOV.UK). Cannabidiol (CBD) guidance. Updated 28 August 2026; checked 19 November 2026.
- Leino AD et al. Evidence of a clinically significant drug-drug interaction between cannabidiol and tacrolimus. American Journal of Transplantation, 2019. PMID 31012522.
- So GC et al. A Phase I trial of the pharmacokinetic interaction between cannabidiol and tacrolimus. Clinical Pharmacology and Therapeutics, 2025. PMID 39601108.
- Cuñetti L et al. Chronic pain treatment with cannabidiol in kidney transplant patients in Uruguay. Transplantation Proceedings, 2018. PMID 29579828.
- Cuñetti L et al. Drug-drug interaction between cannabidiol, cyclosporine, and mycophenolate mofetil: a case report. Transplantation Proceedings, 2024. PMID 38212169.
- Yamaori S et al. Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol. Life Sciences, 2011. PMID 21356216.
- Support lines: Kidney Care UK Support Line; Liver UK nurse-led helpline; Crohn’s and Colitis UK helpline; Arthritis UK helpline. All checked 19 November 2026.
General information, not medical advice. Evopure makes CBD food supplements, and we don’t recommend starting CBD alongside immunosuppressants without your specialist team’s OK. For more, see can CBD interact with medication? and CBD side effects. Evopure is not connected with the makers of any medicine named here.





































